Like any medication, any new and existing benefits of GLP-1s are only valuable when people can access these medications and properly take them as prescribed, said Dr
one time I showed up to class with a bag of Cheetos, and my instructor was like, "No, absolutely not
Request a formulary exception
17 Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
We have also incorporated recent key presentations from scientific meetings, systematic reviews, and meta-analyses when available
As an independent agent, youve probably fielded more than a few phone calls lately from clients stressing over the sky-high costs of weight-loss medications like Wegovy or Zepbound